INMD - InMode Ltd.
| Previous Close | 22.78 |
| Open | 22.40 |
| Bid | 20.65 x 900 |
| Ask | 20.70 x 900 |
| Day's Range | 20.56 - 22.69 |
| 52 Week Range | 13.06 - 23.73 |
| Volume | 567,676 |
| Avg. Volume | 1,273,533 |
| Market Cap | 658.976M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | 21.07 |
| EPS (TTM) | 0.98 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.05 |
- PR Newswire
InMode Ltd. Announces Exercise of Over-Allotment Option
LAKE FOREST, Calif., Aug. 20, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode") announced today the issuance and sale of an additional 500,000 ordinary shares pursuant to the partial exercise of the underwriters' over-allotment option in connection with InMode's initial public offering. The additional shares were sold at the initial offering price of $14.00 per ordinary share, generating additional gross proceeds of approximately $7.0 million and bringing the total gross proceeds to InMode from the offering, before deducting underwriting discounts and commissions and other offering expenses, to approximately $77.0 million.
- Investor's Business Daily
Paula Abdul-Backed Medical IPO Goes Straight Up For Second Day
InMode stock popped for a second day running Thursday after the Paula Abdul-backed medical aesthetics company reported strong revenue growth in the second quarter ended June 30.
- Motley Fool
Why Purple Innovation, Presidio, and InMode Jumped Today
Good news from these companies helped them avoid a big market sell-off.
- Bloomberg
Paula Abdul Helps Newly-Public Skin Treatment Firm InMode Soar
(Bloomberg) -- Newly public InMode Ltd. surged Wednesday after naming of Paula Abdul as a brand ambassador for its alternatives to cosmetic surgery and strong second-quarter results.Shares of the medical technology company soared 25% at 9:50 a.m. Eastern time even as the broader stock market sank. The Lake Forest, California-based company only came public market in a $14 IPO just last week, led by Barclays, UBS, Robert W. Baird and Canaccord Genuity.The provider of medical technologies that focuses on minimally and non-invasive beauty treatments teamed up with the singer and actress, who said she uses InMode’s BodyTite and FaceTite technology as an alternative to traditional cosmetic surgery.InMode reported second-quarter revenue of $38.8 million, a 55% increase from the year prior, with margins that increased. The company’s chief executive praised the results and said in a statement that the results “are consistent with both our reported expectations and the positive trends we are continuing to see in our business.”To contact the reporter on this story: Bailey Lipschultz in New York at blipschultz@bloomberg.netTo contact the editors responsible for this story: Catherine Larkin at clarkin4@bloomberg.net, Scott SchnipperFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
- PR Newswire
InMode Reports Second Quarter 2019 Financial Results; Record Quarterly Revenue of $38.8 Million Reflects Growth of 55% Over Prior Year
Net Income Increased 109% Over Prior Year to $15.8 Million InMode Completed a Successful Initial Public Offering with Gross Proceeds of $70 Million LAKE FOREST, Calif. , Aug. 13, 2019 /PRNewswire/ -- InMode ...
- PR Newswire
Paula Abdul Announced as InMode Brand Ambassador
LAKE FOREST, Calif., Aug. 13, 2019 /PRNewswire/ -- International Pop Icon Paula Abdul has made her mark in this industry as an award-winning dancer and choreographer, singer, actress, and television personality with six number-one singles on the Billboard Hot 100, Emmy and Grammy Awards, and numerous other accolades. Paula has agreed to join InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company") as a brand ambassador to share her positive experience with the Company's BodyTite, FaceTite and Morpheus8 technologies.
- PR Newswire
InMode Ltd. Announces Closing of Initial Public Offering
LAKE FOREST, Calif., Aug. 12, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode") announced today the closing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share. The aggregate gross proceeds, before deducting underwriting discounts and commissions and other offering expenses, to InMode from the offering were approximately $70.0 million. Barclays Capital Inc. and UBS Securities LLC acted as the representatives of the underwriters and joint book-running managers for the offering.
- PR Newswire
InMode Ltd. Announces Pricing of Initial Public Offering
LAKE FOREST, Calif., Aug. 7, 2019 /PRNewswire/ -- InMode Ltd. ("InMode"), announced today the pricing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share. The underwriters of the offering will also have a 30-day option to purchase up to an additional 750,000 ordinary shares from InMode at the initial public offering price.
- Benzinga
Inmode IPO: What You Need To Know
A medical aesthetic company is testing the IPO waters this week. Will investment in the shares give a facelift? The IPO Terms Yokneam, Israel-based Inmode Ltd. has filed with the SEC a preliminary prospectus ...
